Compare Recursion Pharmaceuticals Inc (RXRX) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Western Digital Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $4.01 (market cap $2.14B), while Western Digital Corp trades at $398.6 (market cap $147.23B). The key difference: Western Digital Corp is far larger — about 68.8× Recursion Pharmaceuticals Inc's market cap, and Western Digital Corp pays a 0.15% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Recursion Pharmaceuticals Inc for 22 Days and Western Digital Corp for 37 Days on average.
| RXRX | WDC | |
|---|---|---|
Market Cap | $2.14B | $147.23B |
Volume | 30,789,535 | 9,341,468 |
Sector | Health | Technology |
52-Week High | $6.79 | $746.23 |
52-Week Low | $2.84 | $113.13 |
Typical Hold Time | 22 Days | 37 Days |
Enterprise Value | $1.66B | $146.70B |
Dividend Yield | — | 0.15% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RXRX trades at $4.27, down 7.78% today, with technical indicators showing a bullish trend despite recent weakness. The company reported Q2 2026 earnings miss after two consecutive beats, with revenue declining to $54 million in 2026 from $74 million in 2025. While maintaining a negative net income margin of -961.97%, RXRX continues to expand its AI-powered drug discovery platform through strategic partnerships with Tempus and Roche.
The stock presents high-risk growth potential with strong analyst support (40% buy rating) but faces significant execution challenges. Investment appeal hinges on successful pipeline development and commercialization of AI drug discovery technology, though persistent losses and declining revenue create substantial downside risk for shareholders.
Western Digital (WDC) trades at $405.21, down 1.42% amid recent volatility driven by competitive concerns. The stock shows strong fundamental performance with three consecutive earnings beats and exceptional profitability metrics including 71.97% net margin and 131.02% ROE. Technical indicators signal bearish momentum with the price testing key support at $400, while analyst consensus remains overwhelmingly bullish with a $647.58 price target representing 60% upside potential.
WDC presents a compelling growth opportunity driven by AI storage demand and operational excellence, though near-term headwinds include increased competition from Toshiba's production expansion and market volatility. The company's strong cash flow generation and improving balance sheet support long-term value creation, making it attractive for investors with moderate risk tolerance seeking exposure to the data storage sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
